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Abstract
BACKGROUND
About one-third of refractory irritable bowel syndrome (IBS) cases are caused by
gastrointestinal (GI) infection/inflammation, known as post-infectious/post-
inflammatory IBS (PI-IBS). Although it is known that intestinal microbiota and
host NOD-like receptor family pyrin domain containing 6 (NLRP6) inflammsome
signaling are closely related to PI-IBS and moxibustion has a therapeutic effect on
PI-IBS, whether moxibustion regulates the intestinal flora and host NLRP6 events
in PI-IBS remains unclear.
AIM
To examine the regulatory effect of moxibustion on intestinal microbiota and host
NLRP6 inflammatory signaling in PI-IBS.
METHODS
Sprague-Dawley rats were divided into a normal control group, a model control
group, a mild moxibustion group, and a sham mild moxibustion group. PI-IBS
rats in the mild moxibustion group were treated with moxibusiton at bilateral
Tianshu (ST 25) and Zusanli (ST36) for 7 consecutive days for 10 min each time.
The sham group rats were given the same treatment as the mild moxibustion
group except the moxa stick was not ignited. Abdominal withdrawal reflex
(AWR) score was measured to assess the visceral sensitivity, and colon
histopathology and ultrastructure, colonic myeloperoxidase (MPO) activity, and
serum C-reactive protein (CRP) level were measured to evaluate low-grade
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colonic inflammation in rats. The relative abundance of selected intestinal
bacteria in rat feces was detected by 16S rDNA PCR and the NLRP6
inflammsome signaling in the colon was detected by immunofluorescence, qRT-
PCR, and Western blot.
RESULTS
The AWR score was significantly decreased and the low-grade intestinal
inflammation reflected by serum CRP and colonic MPO levels was inhibited in
the mild moxibustion group compared with the sham group. Mild moxibustion
remarkably increased the relative DNA abundances of Lactobacillus,
Bifidobacterium, and Faecalibacterium prausnitzii but decreased that of Escherichia
coli in the gut of PI-IBS rats. Additionally, mild moxibustion induced mRNA and
protein expression of intestine lectin 1 but inhibited the expression of IL-1β, IL-18,
and resistance-like molecule β by promoting the NLRP6 and reducing the mRNA
and protein expression of apoptosis-associated speck-like protein containing
CARD (ASC) and cysteinyl-aspartate-specific proteinase 1 (Caspase-1). The
relative DNA abundances of Lactobacillus, Bifidobacteria, Faecalibacterium
prausnitzii, and Escherichia coli in each group were correlated with the mRNA and
protein expression of NLRP6, ASC, and Caspase-1 in the colon.
CONCLUSION
These findings indicated that mild moxibustion can relieve low-grade GI
inflammation and alleviate visceral hypersensitivity in PI-IBS by regulating
intestinal microbes and controlling NLRP6 inflammasome signaling.
Key words: Moxibustion; Post-inflammation irritable bowel syndrome; Intestinal
microbes; NLRP6 inflammasome; Intestinal inflammation; Visceral hypersensitivity;
Traditional Chinese medicine
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Core tip: Moxibustion has been shown to have a therapeutic effect on post-
infectious/post-inflammatory irritable bowel syndrome (PI-IBS). However, it is unclear
whether moxibustion achieves its therapeutic effect by regulating intestinal microbiota
and inflammatory responses in PI-IBS. In this study, we found that visceral
hypersensitivity and low-grade intestinal inflammation in PI-IBS rats were significantly
inhibited by 7-d mild moxibustion treatment. This treatment effect of moxibustion may
be related to regulating the relative abundances of selected gut microbes and controlling
NLRP6 inflammasome signaling.
Citation: Bao CH, Wang CY, Li GN, Yan YL, Wang D, Jin XM, Wu LY, Liu HR, Wang XM,
Shi Z, Wu HG. Effect of mild moxibustion on intestinal microbiota and NLRP6
inflammasome signaling in rats with post-inflammatory irritable bowel syndrome. World J
Gastroenterol 2019; 25(32): 4696-4714
URL: https://www.wjgnet.com/1007-9327/full/v25/i32/4696.htm
DOI: https://dx.doi.org/10.3748/wjg.v25.i32.4696
INTRODUCTION
Irritable bowel syndrome (IBS) is a common functional gastrointestinal (GI) disorder
with associated symptoms of abdominal pain and distention,  dysphoria,  and/or
changes of defecation shape. The incidence of IBS is 11.2% worldwide and 5%-6% in
China[1]. One-third of IBS cases are caused by GI infection/ inflammation, which is
commonly defined as post-infectious/post-inflammatory IBS (PI-IBS)[2]. PI-IBS causes
continual  IBS symptoms after  acute GI infection with Shigella,  Escherichia  coli,  or
Campylobacter  jejuni[3,4].  Notably,  the  clinical  symptoms  (abdominal  pain  and
diarrhea)[2] of PI-IBS resemble those of diarrhea-predominant IBS (IBS-D)[5].
Recent studies[6-8] showed altered abundance and diversity of intestinal microflora
in  the  GI  tract  of  PI-IBS  patients.  The  differences  lie  in  the  augmentation  of
Bacteroidetes, decline of Clostridium, and decrease in mucosal microbial diversity and
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stability,  all  of  which are negatively correlated with the lymphocyte ratio in the
mucosal lamina propria[7,8]. Barman et al[9] showed that there was an approximately
95% decrease in the total number of bacteria in the cecum and colon after peroral
Salmonella enterica serovar Typhimurium infection and the mice simultaneously suffered
from severe  diarrhea  on  day  7  post-infection.  Moreover,  alteration  of  intestinal
microbiota triggers the intestinal mucosal immune system to cause ongoing low-
grade  intestinal  inflammation[10].  When pathogenic  microorganisms  invade  and
stimulate  the  gut,  nucleotide-binding and oligomerization domain-like  receptor
(NLR) family pyrin domain 6 (NLRP6) binds to an apoptosis-associated speck-like
protein containing CARD (ASC) and recruits a cysteinyl-aspartate-specific proteinase
1 (Caspase-1)  that self-cleaves into activated Caspase-1.  The activated Caspase-1
cleaves the precursors of the inflammatory cytokines interleukin 1β (pro-IL-1β) and
IL-18 (pro-IL-18) to form active mature peptides, which are delivered extracellularly
and thus cause low-grade intestinal inflammation[11].  Moreover, IL-18 induces the
expression of intestine lectin 1(ITLN1) and resistance-like molecule β (RELMβ), both
of which play pivotal roles in gut inflammatory response. ITLN1 is associated with
secretory function of intestinal goblet cells and is involved in gut immunity while
RELMβ has a positive correlation with the level of gut inflammation[12-14].
Conventional treatments for IBS have limitations such as a high risk of side effects
and long-term drug administration[15,16]. Moxibustion treatment has effects in disease
amelioration and improvement of life quality of IBS-D patients, and provides more
benefits  than pharmacotherapy[16,17].  Our previous study found that  moxibustion
decreased gut relative DNA abundances of Prevotella, Bacteroides, and Clostridium XI,
increased  those  of  Lactobacillus  and  Clostridium  XIVa,  and  improved  the  gut
microbiota alpha diversity in a chronic visceral pain model of IBS in rats[18]. Given the
importance  of  NLRP6  inflammasome  signaling  in  the  intestinal  mucosa  in
maintaining the stability of gut microbiota and intestinal homeostasis[19,20], this study
tested the hypothesis that moxibustion may relieve visceral hypersensitivity of PI-IBS
by regulating intestinal microbiota and NLRP6 inflammasome signaling mediated GI
tract inflammation.
MATERIALS AND METHODS
This  experiment  protocol  was approved by the standardizing laboratory animal
ethical  review  of  Shanghai  University  of  Traditional  Chinese  Medicine  and
implemented according to experimental protocol completely (Ethical review code:
SZY201711006).
Animals and model preparation
Pathogen-free male Sprague-Dawley rats (150 ± 20 g) were fed adaptively for 7 d with
drinking water ad libitum. All rats were provided by the Animal Experimental Center
of Shanghai University of Traditional Chinese Medicine [License number: SCXK (Hu)
2017-0005]. The rats were randomly divided into a normal control group and a model
control group. PI-IBS was induced in rats with 2,4,6-trinitrobenzenesulfonic acid
(TNBS)[21]. No treatment was given to the normal control group. One normal rat and
two model  rats  were  randomly selected on each of  the  days  7,  14,  21,  and 28  to
observe their colonic mucosal structure and histopathology. Abdominal withdrawal
reflex  (AWR) [22]  scores  were  assessed  to  determine  whether  the  model  was
successfully  established.  The AWR scores  were  assessed under  the  induction of
balloon dilation for colorectal distension (CRD). All rats were fasted for 12 h except
for drinking water. A cotton swab was used to stimulate the contraction of the anus
for promoting defecation. A small balloon dipped in liquid paraffin was then slowly
inserted into the colon to 3 cm. Subsequently, the rats were fixed on a table and given
20, 40, 60, and 80 mmHg pressure stimulation successively. The Al-Chaer method was
used to evaluate the criterion-referenced AWR score[22]. The criteria (score) were: 0, no
reaction to CRD; 1, the body remains immobile or head moves slightly; 2, abdominal
muscle  contraction;  3,  the  abdominal  wall  lifts  from  the  bottom  and  contracts
obviously; and 4, body arching along with the pelvic and scrotum lifting. The same
pressure stimulations were performed three times and the average score was taken as
the final score.
Group division and moxibustion implementation
The TNBS-treated PI-IBS rats were further subdivided into a model control group, a
mild moxibustion group, and a sham moxibustion group. A normal control group
was also established. For mild moxibustion, bilateral Zusanli (ST 36) and Tianshu (ST
25)  acupoints  were  selected  based  on  the  locations  described  in  Experimental
Acupuncture[23], which are similar to our previous studies[24,25]. A moxa stick of 5 mm
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in diameter was ignited and placed 2-3 cm above the selected points for 10 min per
day for 7 d of continuous treatment. The sham moxibustion group was given the same
treatment as the mild moxibustion group except that an unlit moxa stick was used
(Figure 1). The model control group and the normal control group were given the
same fixation (The forelimbs and hind limbs of the rats were fixed on the fixation
device) as the mild moxibustion group without any intervention.
AWR score
After the intervention was finished,  the AWR scores were assessed as described
above.
Protocols for collecting specimens of feces, serum, and colonic tissues
Rat feces were collected after the AWR scores were assessed. A swab was used to
touch the perianal skin of the rats to collect 2-3 capsules of feces, which were then
immediately  stored  in  freezing  tubes  at  -80  °C.  Anesthesia  was  performed  by
intraperitoneal injection of 2% sodium barbiturate (0.3 mL/100 g). Blood samples
collected from the abdominal aorta were transferred into a cryogenic microcentrifuge
tube after 1-h standstill and centrifuged for 20 min (3000 rpm) to collect the serum.
Distal colonic tissues (6 cm above the first lymph node of the anus) were rinsed with
normal saline to remove the surrounding connective tissue and fat,  and then the
lesions in the colonic mucosa were scored and photographed. The criteria of colonic
mucosa damage score was according to Wallace et al[26].  After scoring, the colonic
tissues were then stored in 4% paraformaldehyde or liquid nitrogen.
Hematoxylin and eosin (HE) staining
The colonic tissues that were drained from 4% paraformaldehyde were embedded in
paraffin and cut into 4 μm slices.  The sections were processed with xylene I  and
xylene II  for 20 min successively. Subsequently, the sections were hydrated with
anhydrous ethanol, 90% ethanol, 80% ethanol, and 70% ethanol sequentially with 3
min of treatment of each round. Then sections were treated with hematoxylin stain for
1.5  min,  1%  hydrochloric  acid  alcohol  for  4  s,  and  eosin  for  2  min.  The  his-
topathological findings were observed under an optical microscope and analyzed
according  to  the  criteria  in  the  literature  published  by  Park  et  al[27].  The  his-
topathological score includes severity of inflammation, extent of inflammation, and
crypt damage, with a score of 0-9.
Enzyme linked immunosorbent assay (ELISA)
The serum C-reactive protein (CRP) levels and myeloperoxidase (MPO) activities in
colonic tissues of rats were measured by ELISA (Shanghai Yuanye Biological Co.,
Shanghai, China). The concentrations of diluted serum samples were 1800 μg/L, 1200
μg/L,  600  μg/L,  300  μg/L,  150  μg/L,  and  50  μl  per  well,  respectively.  The
concentrations of homogenized colonic tissues were 120 U/L, 80 U/L, 40 U/L, 20
U/L, and 10 U/L with 50 μL of equal sampling volume.
Extraction of total DNA of gut microbiota
Thawing feces after freezing (0.2 g) were dissolved into 1.5 mL of 0.05 M phosphate
buffered saline (PBS), blended for 5 min, and centrifuged three times (1000 rpm; 15
min/time). The supernatant was collected and then centrifuged for another 10 min
(14000 rpm). The supernatant was then removed, and 1 mL of PBS was added into the
precipitate and then centrifuged for 5 min (14000 rpm). The above procedures were
repeated five times.
The precipitate was washed with 1 mL of water, then 100 μL of sterile water and
TritonX-100 were added to the precipitate to mix and lyse the cells. Then, the sample
was centrifuged for 15 s (14000 rpm). Two hundred microliters of supernatant from
the  lysate  was  taken,  extracted  by  phenol  and  chloroform  (1:1)  for  10  s,  and
centrifuged for 15 s (14000 rpm). About 2.5-fold of supernatant volume cold ethanol
was added into the collected supernatant. The mixture was incubated at -20 °C for 1 h
and centrifuged for 1 min (14000 rpm). The supernatant was discarded, and cold
ethanol  was  added  to  the  precipitate  again,  incubated  at  -20  °C  for  1  h,  and
centrifuged for 1 min (14000 rpm). The supernatant was discarded and the DNA
precipitate was dried, dissolved with 50 μL of sterile water, and stored at -20 °C in a
freezer.
16S rDNA PCR
According to the literature[28], the bacterial abundance of Escherichia coli in patients
with IBS is significantly higher than that in healthy people, while the abundance of
Lactobacillus is significantly reduced. The abundance of Bifidobacterium in the gut of
IBS patients is 1.5 times less than that of healthy people[29], and the Faecalibacterium
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Figure 1
Figure 1  Diagram of moxibustion in rats. Rats were immobilized on a fixing frame. A: A moxa stick of 5 mm in
diameter was ignited and placed 2-3 cm above the bilateral Zusanli (ST26) and Tianshu (ST25) for 10 min per day
with 7 d of continuous treatment in the mild moxibustion group; B: The sham moxibustion group was given the same
treatment as the mild moxibustion group except that moxibustion was treated with an unlit moxa stick.
prausnitzii  and its  cultural  supernatant can relieve the intestinal  inflammation[30].
Therefore, Lactobacillus, Bifidobacterium, Faecalibacterium prausnitzii, and Escherichia coli
were selected as the four targeted microbes for research. 16S rDNA PCR was applied
for testing the DNA relative abundance of selected bacteria. The isolated DNA was
amplified by real-time PCR with a total volume of 25 μL recipe: SYBR Green Mix 12.5
μL,  primer  F  0.5  μL,  primer  R  9.5  μL,  double  distilled  water  9.5  μL,  and cDNA
template 2 μL. SYBR Green PCR kit was purchased from ThermoFisher (K0223) and
the  PCR  purification  kit  was  purchased  from  Axygen  (AP-GX-50).  The  primer
sequences are listed in Table 1. Reaction conditions were: 95 °C for 10 min; 40 cycles of
95 °C for 15 s and 60 °C for 45 s; 95 °C for 15 s; 60 °C for 1 min; 95 °C for 15 s; and 60
°C for 15 s. ABI Prism 7300 SDS software was used to analyze the data.
qRT-PCR
The mRNA expression of NLRP6, ASC, Caspase-1, IL-1β, IL-18, ITLN1, and RELMβ
was  detected  by  qRT-PCR.  One  milliliter  of  colonic  tissue  was  added  into  a
homogenate tube containing Trizol reagent, and total RNA was extracted according to
the manufacturer’s  instruction (1596-026;  Invitrogen).  A volume of  25 μL cDNA
reaction  recipe  was  prepared  in  a  sequence  of  RNA-Primer  Mix  12  μL,  5  ×  RT
Reaction Buffer 5 μL, 25 mM dNTPs 1 μL, 25 U/μL RNase Inhibitor 1 μL, 200U/μL M-
MLV Rtase 1 μL, Oligo (dt) 18 primer 1 μL, and DEPC water 4 μL. The products for
qPCR were made in a reaction system containing SYBRGreen Mix 12.5 μL, primer F
0.5 μL, primer R 0.5 μL, ddH2O 9.5 μL, and cDNA template 2 μL. SYBR Green PCR
KIT was purchased from Thermo (K0223), and the Retroscript kit was purchased from
Fermentas (k1622). The primer sequences are listed in Table 2. Reaction conditions
were: 95 °C for 10 min; 40 cycles of 95 °C for 15 s and 60 °C for 45 s; 95 °C for 15 s; 60
°C for 1min; 95 °C for 15 s; and 60 °C for 15 s. ABI Prism 7300 SDS software was used
to analyze the data.
Western blot analysis
Western blot was performed to test the protein expression of NLRP6, ASC, Caspase-1,
IL-1β, IL-18, ITLN1, and RELMβ in the colonic tissue. The colon tissue stock was
taken out from liquid nitrogen. The tissue was weighed, chopped, and placed in a
homogenate tube. Then, a lysis fluid (containing protease and phosphatase inhibitors)
was added to the sample tube to fully lyse the cells at 4 °C. The cells were scraped into
a 1.5 mL Eppendorf tube, heated at 95 °C, and then centrifuged for 15 min (12000
rpm). The supernatant was harvested for protein quantification. The dilutions of
primary antibodies of NLRP6 (Santa Cruz, SC-376434), ASC (Invitrogen, PA5-50915),
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Table 1  Primers used for amplification of selective intestinal microbiota
Microorganism Base sequence
Lactobacillus Primer F 5'-ACGGGAGGCAGCAGTAGGGA-3'
Primer R 5'-AGCCGTGACTTTCTGGTTGATT-3'
Bifidobacterium Primer F 5'-GATTCTGGCTCAGGATGAACGC-3'
Primer R 5'-CTGATAGGACGCGACCCCAT-3'
Faecalibacterium_prausnitzii Primer F 5'-AGATGGCCTCGCGTCCGA-3'
Primer R 5'-CCGAAGAACCTTCTTCCTCC-3'
Escherichia_coli Primer F 5'-CATGCCGCGTGTATGAAGAA-3'
Primer R 5'-CGGGTAACGTCAATGAGCAAA-3'
Caspase-1 (Abcam, Ab1872), IL-1β (Abcam, Ab9722), IL-18 (Abcam, Ab191860), and
GAPDH  (CST,  #5174)  were  1:100,  1:1000,  1:500,  1:1000,  1:1000,  and  1:2000,
respectively.
Immunofluorescence
The protein expression and location of NLRP6, ASC, and Caspase-1 in colonic tissue
were studied by immunofluorescence. The paraffin sections of colon tissue were dried
at 60 °C, plastered with xylene-wax twice, repaired with 0.01 M of sodium citrate
buffer solution for 15 min after gradient alcohol dehydration, and finally washed with
PBS three times. The primary antibody of NLRP6 was goat anti-mouse IgG [Biyuntian
Biotechnology  Co.,  Ltd  (A0428)]  labelled  with  Alexa  Fluor  488;  the  diluted
concentration was 1:500. The primary antibodies of ASC and Caspase-1 were goat
anti-rabbit IgG [Biyuntian Biotechnology Co., Ltd (A0423)] labelled with Alexa Fluor
488; the dilution was 1:100 and incubation temperature was 4 °C. The dilutions of
fluorescent secondary antibody of NLRP6, ASC, and Caspase-1 were 1:200, 1:500, and
1:200, respectively, with 30 min incubation. The protein expression of NLRP6, ASC,
and  Caspase-1  in  the  intestinal  mucosa  was  observed  under  a  laser  confocal
microscope.
Statistical analysis
Statistical analyses were performed using SPSS v21.0 software. Serum CRP level,
colonic MPO activity, relative bacterial abundance, and colonic mRNA and protein
expression  of  NLRP6,  ASC,  Caspase-1,  IL-1β,  IL-18,  ITLN1,  and  RELMβ  are
represented as the mean ± SD. These data were analyzed by one-way analysis of
variance (ANOVA) for  the differences between groups,  and the least  significant
difference test for pairwise comparisons. AWR score, colonic mucosa damage score,
and  histopathological  score  are  shown  as  medians  (P25,  P75).  These  data  were
analyzed by the nonparametric Kruskal-Wallis test. The correlations were measured
by Pearson correlation coefficient.  P  < 0.05 was set  as the threshold of statistical
significance[31,32].
RESULTS
Sixty rats were randomly divided into a normal control group (n = 14) and a model
control group (n = 46). One normal rat and two model rats were randomly selected on
each of the days 7, 14, 21, and 28 to establish a PI-IBS model. During the preparation
of the model, one rat died and the remaining rats in the model control group were
further subdivided into a model control group (n = 13), a mild moxibustion group (n
= 12), and a sham moxibustion group (n = 12). Finally, 10 rats in each of the three
groups were randomly selected, and with the 10 rats in the normal control group, a
total of 40 rats were included in the final statistical analysis.
PI-IBS model
The colonic mucosal surfaces of normal rats on days 7, 14, 21, and 28 were smooth and
the mucosa rugae were clear with full shape and moderate thickness (Figure 2A). The
HE staining results demonstrated that the colonic mucosa of the model control group
had mild hyperemia and edema damage, and the glands appeared neatly arranged
(Figure 2B). Compared to the normal control group, the colonic tissue of rats in the
model control group on day 7 became significantly thickened, congested, and swollen
with no mucosa rugae or ulcers. As seen under the microscope, most of the glandular
structures  disappeared,  the  mucosa  and  submucosa  had  severe  infiltration  of
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Table 2  Primers used for amplification of NLRP6, ASC, Caspase-1, and GAPH mRNA
mRNA Base sequence
NLRP6 Primer A 5'-AAGGTGAAGGAGAGGAATG-3'
Primer B 5'-GAAGAGCCGATTGAAAGTG-3'
ASC Primer A 5'-TGCTGGATGCTCTGTATGG-3'
Primer B 5'-CAAGTAGGGCTGTGTTTGC-3'
Caspase-1 Primer A 5'-GACAAGCCCAAGGTTATC-3'
Primer B 5'-GGCCTTCTTAATGCCATC-3'
IL-1β Primer A 5'-AAGGTGAAGGAGAGGAAT-3'
Primer B 5'-GAAGAGCCGATTGAAAGTG-3'
IL-18 Primer A 5'-TGCTGGATGCTCTGTATGG-3'
Primer B 5'-CAAGTAGGGCTGTGTTTGC-3'
GAPDH Primer A 5'-GTCGGTGTGAACGGATTTG-3'
Primer B 5'-TCCCATTCTCAGCCTTGAC-3'
inflammatory cells, and the submucosa was congested with edema.
By day 28,  the thickness  of  the colonic  tissue was gradually  reduced,  and the
hyperemia and edema were relieved, meanwhile the mucosal rugae were clear and
had  returned  to  normal.  The  gland  boundary  was  clear  and  neat  under  the
microscope, the lamina propria had less inflammatory cell infiltration than that on
day 7, and the submucosa exhibited mild hyperemia and edema.
AWR scores were calculated for the normal control group and model control group
on day 28. Compared with the normal control group, the rats in the model control
group had significantly  higher  AWR scores  under  20  mmHg,  40  mmHg,  and 60
mmHg pressure stimulation (P < 0.01), respectively, which indicated that the model
control group had obviously increased gut sensitivity (Figure 2C). The higher AWR
scores  and  alterations  in  colonic  mucosal  histopathology  indicated  higher  gut
sensitivity after low-grade inflammation and the successful establishment of the PI-
IBS model.
AWR scores
The model  control  group had significantly  higher  AWR scores  compared to  the
normal  control  group  under  20  mmHg,  40  mmHg,  and  60  mmHg  pressure
stimulation, respectively (P < 0.01). The rats in the mild moxibustion group possessed
lower AWR scores than those of the model control group under 20 mmHg, 40 mmHg,
and 60 mmHg pressure stimulation, respectively (P < 0.01). The sham moxibustion
group also exhibited lower AWR scores than the model control group, but there was
no significant difference between the two groups in AWR scores under different
stimulating pressures (P > 0.05) (Figure 3A). These results indicated that moxibustion
significantly alleviated gut hypersensitivity and increased pain threshold of rats in the
model  control  group.  This  effect  was  significantly  better  than  that  of  sham
moxibustion.
Colonic mucosal damage
The colonic mucous membrane of normal rats was smooth and the mucosal ruga were
clear  and had an  integral  shape  with  moderate  thickness.  The  model  and sham
moxibustion groups displayed thicker colonic tissues than normal rats with visible
pathological changes such as mild hyperemia and edema without ulcers. The mild
moxibustion group had smooth colonic mucous membranes and clear and integral-
shaped mucosal rugae. The bowel walls of rats in the mild moxibustion group were
slightly thicker than those of the normal control group, but still thinner than those of
the model control group and sham moxibustion group. Furthermore, the bowel walls
of rats in the mild moxibustion group had mild hyperemia but no ulcers (Figure 3B).
The rats of  the model control  group, the mild moxibustion group, and the sham
moxibustion group had higher  colonic  mucosa damage scores  than those  of  the
normal control group. However, there was no significant difference among all these
groups (Figure 3C).
Colonic histopathology
Microscopically, the colonic mucous membrane of normal rats was smooth, the glands
were  neatly  arranged  with  no  hyperemia  or  edema,  and  no  inflammatory  cell
infiltration was observed. The model control group had neatly integrated membrane
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Figure 2
Figure 2  A rat post-infectious/post-inflammatory irritable bowel syndrome model established by 2,4,6-trinitrobenzenesulfonic acid induction. A: Gross
structure; B: Pathology of the normal control group and model control group on days 7, 14, 21, and 28; C: Abdominal withdrawal reflex scores of the normal and model
control groups under different pressure stimulations on day 28 after model generation. bP < 0.01 vs normal control group. AWR: Abdominal withdrawal reflex.
WJG https://www.wjgnet.com August 28, 2019 Volume 25 Issue 32
Bao CH et al. Effect of moxibustion on PI-IBS in rats
4703
Figure 3
Figure 3  Effects of mild moxibustion on abdominal withdrawal reflex scores and low-grade inflammation of the colon in each group. A: Abdominal
withdrawal reflex score; B: Observed gross structure; C: Histological score; D: Observed histopathology; E: Pathological score. bP < 0.01 vs normal control group; dP
< 0.01 vs model control group. AWR: Abdominal withdrawal reflex.
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with a messy gland arrangement, and structure of the glands could not be identified
under the microscope.  The mucosa and submucosa were infiltrated with a small
number of inflammatory cells, giving an appearance of submucosal hyperemia and
edema. The mild moxibustion group harbored integrated membrane with the glands
neatly arranged, and no inflammatory infiltration was observed. The submucosa of
some rats of the mild moxibustion group was mildly congested and swollen. The
sham moxibustion group displayed similar colonic pathology as the PI-IBS model.
These  observations  suggested  that  mild  moxibustion  ameliorated  the  intestinal
mucosal pathological score of PI-IBS rats and displayed better efficiency than sham
moxibustion in the treatment of PI-IBS rats (Figure 3D). Both the model control group
and the sham moxibustion group had higher histopathological scores than the normal
control group and the mild moxibustion group. However, there was no statistical
difference among all these groups (Figure 3E).
Colonic ultrastructure
The colonic  ultrastructure  of  rats  in  the  normal  control  group showed neat  and
regular shaped villi, and close links between epithelial cells, and the mitochondria
were oval shaped with clear and regular cristae. In the model control group, however,
the colonic villi  were partially missing, and the epithelial space in model control
group rats  became wider  than that  in  the  normal  control  group.  The number of
desmosomes decreased, the mitochondria became swollen with larger sizes, the inner
crests were blurred, and some vacuoles appeared.
Colonic villi of rats in the mild moxibustion group were neat with regular shape
and length. No significant increase in epithelial cell gaps was observed, the number of
desmosomes increased, and the shapes of the mitochondria and cristae were regular
and  clear.  Rats  in  the  sham  moxibustion  group  demonstrated  almost  the  same
alterations as the model control group. These results indicated that mild moxibustion
improved the ultrastructure of the colonic tissues to a far greater extent than that of
sham moxibustion (Figure 4).
Serum CRP levels and colonic MPO activity
The model control group had significantly higher colonic MPO activities and serum
CRP levels than the normal control group (P  < 0.01), while the mild moxibustion
group had significantly lower colonic MPO activities and serum CRP levels (P < 0.01)
than the model  control  group.  The sham moxibustion group also had decreased
colonic MPO activities and serum CRP levels than the model control group, but this
difference was not statistically significant. In contrast, the mild moxibustion group
had significantly lower colonic MPO activities and serum CRP levels than the sham
moxibustion group (P < 0.01) (Figure 5). These results revealed that mild moxibustion
significantly  decreased  colonic  MPO  activities  and  serum  CRP  levels,  relieved
intestinal  inflammation,  and  had  a  better  therapeutic  effect  than  the  sham
moxibustion group in the treatment of PI-IBS rats.
Relative bacterial abundance in the intestine
Sequencing  analysis  indicated  that  relative  DNA  abundances  of  Lactobacillus,
Bifidobacteria,  and Faecalibacterium prausnitzii  in  gut  microbiota  community were
remarkably lower in the model control group than in the normal control group (P <
0.01), and the DNA abundance of Escherichia coli was significantly higher (P < 0.01).
Compared  with  the  model  control  group,  the  relative  DNA  abundances  of  the
Lactobacillus, Bifidobacteria, and Faecalibacterium prausnitzii in the mild moxibustion
group were significantly increased (P < 0.05) while the relative DNA abundance of
Escherichia coli was significantly decreased (P < 0.01). The relative DNA abundances of
the  four  aforementioned kinds of  bacteria  in  the  sham moxibustion group were
almost the same as those of the model control group.
Compared with the sham moxibustion group, the mild moxibustion group had
higher relative DNA abundances of Lactobacillus, Bifidobacteria, and Faecalibacterium
prausnitzii (P < 0.01) and lower DNA abundance of Escherichia coli (P < 0.01) (Figure 6).
These findings suggested that mild moxibustion significantly increased the relative
DNA abundances  of  intestinal  Lactobacillus,  Bifidobacterium,  and Faecalibacterium
prausnitzii but reduced the relative abundance of Escherichia coli in the gut microbiota
of PI-IBS rats, which was superior to sham moxibustion in adjusting the equilibrium
of relative gut microbiome.
The mRNA and protein expression of NLRP6, ASC, and Caspase-1
The model control group displayed significantly lower mRNA and protein expression
of NLRP6 and markedly higher mRNA and protein expression of ASC and Caspase-1
in comparison with the normal control group (P  < 0.01).  There was no statistical
significance  between  the  model  control  group  and  mild  moxibustion  group  in
WJG https://www.wjgnet.com August 28, 2019 Volume 25 Issue 32
Bao CH et al. Effect of moxibustion on PI-IBS in rats
4705
Figure 4
Figure 4  Effects of mild moxibustion on colonic ultrastructure of rats with post-infectious/post-inflammatory irritable bowel syndrome.
increasing the mRNA expression of NLRP6, but statistical significance was observed
between these two groups in increasing the protein expression of NLRP6 (P < 0.01).
The mRNA and protein expression of ASC and Caspase-1 in the mild moxibustion
group was significantly lower than that of the model control group (P < 0.01). NLRP6,
ASC, and Caspase-1 mRNA and protein expression in the sham moxibustion group
was similar to that of the model control group.
Compared with the sham moxibustion group, the NLRP6 mRNA (P < 0.05) and
protein  expression  (P  <  0.01)  in  colonic  tissue  of  the  mild  moxibustion  group
increased significantly, while the ASC and Caspase-1 mRNA (P < 0.01) and protein
expression (P  < 0.01) significantly decreased (Figure 7). Moreover, the expression
locations of NLRP6, ASC, and Caspase-1 were mostly distributed in the cytoplasm of
mucosal  cells.  The  normal  and  mild  moxibustion  groups  had  higher  NLRP6
expression intensity but lower ASC and Caspase-1 expression intensity than the
model and sham moxibustion groups (Figure 8). These findings indicated that mild
moxibustion, rather than sham moxibustion, could remarkably enhance the protein
expression of  NLRP6 and inhibit  the mRNA and protein expression of  ASC and
Caspase-1 in the PI-IBS rat model.
The mRNA and protein expression of IL-1β and IL-18
The IL-1β and IL-18 mRNA and protein expression was significantly increased in the
model control group (P < 0.01) compared with the normal control group. However,
the mild moxibustion group displayed significantly lower expression levels of IL-1β
and IL-18 mRNA (P < 0.01) and protein (P < 0.01), while the sham moxibustion group
had similar expression levels of IL-1β and IL-18 mRNA and protein compared with
model control group. The IL-1β and IL-18 mRNA and protein expression in the mild
moxibustion group was significantly decreased compared with that  of  the sham
moxibustion group (P < 0.01) (Figure 9). These suggested that mild moxibustion could
significantly inhibit the IL-1β and IL-18 mRNA and protein expression in intestinal
tissues of PI-IBS rats, and exhibit a better effect than sham moxibustion in improving
IL-1β and IL-18 expression.
The mRNA and protein expression of ITLN1 and RELMβ
Compared with the normal control group, the mRNA expression level of ITLN1 in the
model control group was significantly lower (P < 0.01) while the mRNA expression of
RELMβ was higher (P < 0.01); the protein expression of RELMβ also increased but
without statistical significance. Compared with the model control group, the mRNA
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Figure 5
Figure 5  Effects of mild moxibustion on serum C-reactive protein levels and colonic myeloperoxidase activities in post-infectious/post-inflammatory
irritable bowel syndrome rats in each group. A: Serum C-reactive protein levels; B: Myeloperoxidase activities. bP < 0.01 vs normal control group; dP < 0.01 vs
model control group; fP < 0.01 vs sham moxibustion group. CRP: C-reactive protein; MPO: Myeloperoxidase.
expression of ITLN1 in the mild moxibustion group was notably higher (P < 0.05),
while the mRNA expression of RELMβ was notably lower (P  < 0.01);  the protein
expression of RELMβ was decreased without statistical significance. The mRNA and
protein expression levels of ITLN1 and RELMβ in the sham moxibustion group were
similar to those of the model control group.
Compared with the sham moxibustion group, the mRNA expression of ITLN1 in
the mild moxibustion group was significant higher (P < 0.01) while the mRNA and
protein expression of RELMβ was significant lower (P < 0.05). The protein expression
of ILTN1 in the four groups varied but without statistical significance (Figure 10).
These results suggested that mild moxibustion could remarkably increase the mRNA
expression of ITLN1 whereas the mRNA expression of RELMβ in colon tissues of PI-
IBS rats was inhibited. Therefore, mild moxibustion showed a better treatment effect
than sham moxibustion.
Correlation of selected bacteria and NLRP6 inflammasome signaling
The relative DNA abundances of  Lactobacillus,  Bifidobacteria,  and Faecalibacterium
prausnitzii in feces of rats in each group were shown to have positive correlations with
the  mRNA  and  protein  expression  of  NLRP6  in  the  colon,  and  have  negative
correlations  with  those  of  ASC  and  Caspase-1  in  the  colon.  The  relative  DNA
abundance of  Escherichia coli  in feces of  rats in each group were showed to have
negative correlations with the mRNA and protein expression of NLRP6 in the colon,
and positive correlations with those of ASC and Caspase-1 in the colon (Table 3).
DISCUSSION
In this study, we demonstrated that mild moxibustion on bilateral Tianshu (ST 25)
and Zusanli (ST 36) points regulated visceral hypersensitivity in rats with TNBS-
induced PI-IBS. The possible events behind these effects may include modulating the
intestinal  microbiota  and  NLRP6  inflammasome  signaling.  A  close  association
between regulating selected bacteria and NLRP6 inflammasome signaling was linked
to illustrate a possible way for the therapeutic effect of mild moxibustion on PI-IBS
and to provide an effective therapeutic plan for moxibustion treatment of PI-IBS.
Compared with the model control group, mild moxibustion treatment significantly
lowered AWR scores under 20, 40, and 60 mmHg pressure stimulation, while sham
acupuncture did not. These results indicated that mild moxibustion is effective in
downregulating gut sensitivity and increasing pain threshold in IBS.
The  PI-IBS  rats  showed  low-grade  intestinal  inflammation  after  successful
establishment  of  the  rat  model.  Mild  moxibustion  improved  histological  and
ultrastructural features of the colon, serum CRP levels, and colonic MPO activities.
Specifically, the colon of rats in the mild moxibustion group had smooth mucous
membrane with mucosal rugae in a clear and integral shape and a slightly thicker
bowel  wall,  clear  mucosa  without  inflammatory  infiltration,  and  some  mildly
congested and swollen submucosa.  The damage caused by TNBS was alleviated
compared to that of the model control group. Transmission electron microscopic
images showed that colon villi of rats in the mild moxibustion group were neat with
regular shape and equal length. There were no significant increase in the epithelial
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Figure 6
Figure 6  Effects of mild moxibustion on the relative DNA abundances of targeted bacteria in feces of post-infectious/post-inflammatory irritable bowel
syndrome rats in each group. A: Relative DNA abundance of Lactobacillus; B: Relative DNA abundance of Bifidobacterium; C: Relative DNA abundance of
Faecalibacterium prausnitzii; D: Relative DNA abundance of Escherichia coli. bP < 0.01 vs normal control group; cP < 0.05 and dP < 0.01 vs model control group; fP <
0.01 vs sham moxibustion group.
cell  gaps,  the shape of  mitochondria and cristae were regular and clear,  and the
junctions of the intestinal epithelial cells were tight. Collectively, mild moxibustion
effectively relieved colonic mucosal damage and ameliorated low-grade inflammation
in the PI-IBS model.
Serum CRP levels and colonic MPO activities are generally used to evaluate the
degree of inflammation[33-35].  Menees et al[33]  claimed that the results of their meta-
analysis  indicated  that  the  diagnostic  reliability  of  IBS  could  be  improved  by
comprehensive consideration of both IBS symptoms and serum CRP level. Hod et al[34]
found that the average CRP level of 242 IBS patients was significantly higher than that
of 244 healthy subjects. By using a TNBS-induced chronic visceral pain model in mice,
Campaniello et al[35]  found that the MPO activity of the model control group was
significantly increased. Similarly, the increased serum CRP level and colonic MPO
activity of the PI-IBS rats in this study are consistent with the previous studies. After
mild moxibustion treatment, serum CRP level and colonic MPO activity of the mild
moxibustion group were remarkably decreased compared with those of the model
and sham moxibustion groups, indicating that mild moxibustion effectively decreased
the intestinal low-grade inflammation in PI-IBS rats.
We also explored whether mild moxibustion affects certain gut microbes. Previous
studies revealed that the abundance of Escherichia coli  was significantly increased
while the relative DNA abundances of Lactobacillus and Bifidobacteria were remarkably
decreased  in  IBS  patients,  compared  with  healthy  subjects[36].  Lactobacillus  and
Bifidobacteria were found to relieve visceral hypersensitivity and inflammation in PI-
IBS rats[37]. Faecalibacterium prausnitzii had an anti-inflammatory effect as the cultural
supernatant could ameliorate colitis[38]. Therefore, we chose to evaluate Lactobacillus,
Bifidobacteria, Faecalibacterium prausnitzii, and Escherichia coli in this study. We found
that the relative DNA abundances of Lactobacillus, Bifidobacteria, and Faecalibacterium
prausnitzii in gut microbiome of rat feces were increased after mild moxibustion, while
the abundance of Escherichia coli  was decreased after the treatment. These results
demonstrated  that  mild  moxibustion  was  able  to  increase  the  relative  DNA
abundances of probiotic bacteria, decrease harmful bacteria, and balance the bacteria
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Figure 7
Figure 7  Effects of mild moxibustion on the mRNA and protein expression of NLRP6, ASC, and Caspase-1 in the colon of post-infectious/post-
inflammatory irritable bowel syndrome rats in each group. A: The mRNA expression levels of NLRP6, ASC, and Caspase-1; B: The protein expression of NLRP6,
ASC, and Caspase-1. aP < 0.05 and bP < 0.01 vs normal control group; dP < 0.01 vs model control group; eP < 0.05 and fP < 0.01 vs sham moxibustion group.
composition of gut microbiota. The normal expression of NLRP6 and its ligands ASC
and Caspase-1 in the intestinal mucosa is essential for the maintenance of intestinal
microbiota homeostasis[19,20]. Abnormal expression of NLRP6 inflammasome signaling
and its downstream cytokines (IL-1β and IL-18, antibacterial peptide ITLN1, and
RELMβ) in the intestinal mucosa plays important roles in the intestinal microbiota
disturbance and low-grade inflammation in IBS patients. Analyses of the correlations
between the relative DNA abundances of the four bacteria and the protein levels of
NLRP6, ASC, and Caspase-1 showed significant correlations among them. The NLRP6
is a negative regulator that inhibits inflammatory signaling pathway[39] and adjusts IL-
1β and IL-18 expression and other cytokines involved in the inflammatory and innate
immune responses[40,41].
The antibacterial peptide ITLN1 regulates intestinal immunity by affecting goblet
cell  protein  expression,  while  RELMβ  usually  promotes  the  inflammatory
response[13,14].  After  mild moxibustion treatment,  NLRP6 and ITLN1 mRNA and
protein expression in the colonic tissue was increased, while the mRNA and protein
expression levels of ASC, Caspase-1, and downstream cytokines IL-1β, IL-18, and
RELMβ  were  decreased.  The  effect  of  moxibustion  on  NLRP6  inflammasome
signaling in this study was similar to that of Clostridium butyricum intervention[26].
Moreover,  the results showed that mild moxibustion increased the expression of
NLRP6 (the upstream regulatory factor), reduced the expression of ASC and Caspase-
1  to  modulate  NLRP6  inflammasome  signaling,  decreased  the  expression  of
downstream cytokines IL-1β and IL-18, promoted the mRNA and protein expression
of ITLN1, and inhibited the mRNA and protein expression of RELMβ. As a result,
intestinal inflammation was ameliorated and intestinal homeostasis was maintained.
The present  study still  has  some limitations.  We only  explored four  bacterial
species  from  among  various  gut  microbes  that  can  affect  intestinal  low-grade
inflammation and visceral hypersensitivity. Additionally, inhibitors and gene knock-
out  rat  models  were  not  applied  in  this  study  to  measure  the  effects  of  mild
moxibustion on NLRP6 inflammasome signaling.  In the future,  gene sequencing
technology will be introduced to investigate the mechanisms of mild moxibustion in
regulating  gut  microbiota,  and  the  effect  of  mild  moxibustion  on  NLRP6
inflammasome signaling will be tested. This study revealed that mild moxibustion
inhibited intestinal low-grade inflammation via regulating the relative abundance of
gut microbiota and NLRP6 inflammasome signaling, which may be an important
event of mild moxibustion in relieving visceral hypersensitivity in PI-IBS.
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Table 3  Correlations between selective intestinal microbes and mRNA and protein expression of NLRP6, ASC, and Caspase-1
Lactobacillus Bifidobacterium Faecalibacterium_prau-snitzii Escherichia_coli
r P r P r P r P
NLRP6 mRNA 0.550 0.000 0.542 0.000 0.624 0.000 -0.495 0.000
ASC mRNA -0.641 0.000 -0.633 0.000 -0.747 0.000 0.432 0.005
Caspase-1 mRNA -0.656 0.000 -0.688 0.000 -0.737 0.000 0.716 0.000
NLRP6 protein 0.639 0.000 0.750 0.000 0.920 0.000 -0.626 0.000
ASC protein -0.607 0.000 -0.709 0.000 -0.797 0.000 0.606 0.000
Caspase-1 protein -0.654 0.000 -0.669 0.000 -0.749 0.000 0.501 0.001
Figure 8
Figure 8  Effects of mild moxibustion on the protein expression of NLRP6, ASC, and Caspase-1 in the colon of post-infectious/post-inflammatory irritable
bowel syndrome rats. NLRP6, ASC, and Caspase-1 are localized in the cytoplasm of mucosal cells in the mucosal layer of rats in each group.
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Figure 9
Figure 9  Effects of mild moxibustion on the mRNA and protein expression of IL-1β and IL-18 in the colon of post-infectious/post-inflammatory irritable
bowel syndrome rats in each group. A: The mRNA expression levels of IL-1β and IL-18; B: Protein expression levels of IL-1β and IL-18. aP < 0.05 and bP < 0.01 vs
normal control group; dP < 0.01 vs model control group; fP < 0.01 vs sham moxibustion group.
Figure 10
Figure 10  Effects of mild moxibustion on the mRNA and protein expression of ITLN1 and RELMβ in the colon of post-infectious/post-inflammatory irritable
bowel syndrome rats in each group. A: The mRNA expression levels of ITLN1 and RELMβ; B: Protein expression levels of ITLN1 and RELMβ. aP < 0.05 and bP <
0.01 vs normal control group; dP < 0.01 vs model control group; eP < 0.05 and fP < 0.01 vs sham moxibustion group.
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Irritable bowel syndrome (IBS)  is  a  common functional  gastrointestinal  (GI)  disorder with
associated  symptoms  of  abdominal  pain  and  distention,  dysphoria,  and/or  changes  of
defecation  shape.  About  one-third  of  refractory  IBS  cases  are  caused  by  GI
infection/inflammation, known as post-infectious/post-inflammatory IBS (PI-IBS). Moxibustion
has been shown to have a therapeutic effect on PI-IBS but whether moxibustion achieves its
therapeutic  effect  by  regulating  the  intestinal  microbiota  and  host  NLRP6  inflammatory
signaling in PI-IBS remains unclear. Our previous study found that moxibustion decreased gut
relative DNA abundances of Prevotella, Bacteroides, and Clostridium XI, increased the abundances
of Lactobacillus  and Clostridium  XIVa, and improved the gut microbiota alpha diversity in a
chronic visceral pain model of IBS in rats.
Research motivation
The  hypothesis  behind  this  study  is  that  moxibustion  could  relieve  the  low-grade  GI
inflammation and alleviate visceral hypersensitivity of PI-IBS by regulating intestinal microbes
and controlling NLRP6 inflammasome signaling.
Research objectives
The aim of this study was to investigate the possible events behind the therapeutic effect of
moxibustion on PI-IBS rats via regulating gut microbiota and NLRP6 inflammasome signaling.
Research methods
Sixty rats were divided into a normal control group, a model control group, a mild moxibustion
group, and a sham mild moxibustion group. PI-IBS rats in the mild moxibustion group were
given 7 d of continuous moxibustion treatment. The sham group was given the same treatment
as the mild moxibustion group except the moxa stick was not ignited. PI-IBS was induced with
TNBS in rats. Moxibustion was applied to the bilateral Zusanli (ST36) and Tianshu (ST25). The
abdominal  withdrawal  reflex  (AWR) scores  were  assessed under  the  induction of  balloon
dilation for colorectal distension. Haematoxylin and eosin staining was assessed to evaluate the
changes  in  the  colonic  histopathology.  Serum C-reactive  protein  (CRP)  levels  and colonic
myeloperoxidase (MPO) activities in colonic tissues of rats were measured by ELISA. 16S rDNA
PCR was applied for testing the DNA relative abundance of selected intestinal bacteria. Western
blot and qPCR were used to determine the protein and mRNA expression of NLRP6, ASC,
Caspase-1, IL-1β, IL-18, ITLN1, and RELMβ.
Research results
Compared with the normal control group, the PI-IBS model control group had higher AWR
scores, serum CRP levels, and colonic MPO activities. After treatment, the scores were decreased
in  the  moxibustion  group  compared  with  the  model  control  group.  Mild  moxibustion
significantly increased the relative DNA abundances of intestinal Lactobacillus, Bifidobacterium,
and Faecalibacterium prausnitzii but reduced the relative abundance of Escherichia coli in the gut of
PI-IBS rats. Besides, mild moxibustion significantly enhanced the protein expression of NLRP6
and ITLN1 and inhibited the mRNA and protein expression of ASC, Caspase-1, IL-1β, IL-18, and
RELMβ.
Research conclusions
This  study revealed that  mild  moxibustion inhibits  intestinal  low-grade inflammation via
regulating DNA abundances of gut microbes and NLRP6 inflammasome signaling, which may
be an important mechanism of mild moxibustion in relieving visceral hypersensitivity in PI-IBS.
Research perspectives
Our findings may provide an experimental and scientific basis for the effective treatment of PI-
IBS by mild moxibustion.
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